Palantir Sees 30% Revenue Jump in Q3 2024, Raises Revenue Guidance Again
Palantir Technologies (NYSE: PLTR) has raised its annual revenue forecast for 2024 for the third time this year. The company now anticipates full-year revenue between $2.805 billion and $2.809 billion, a boost from its prior guidance of $2.742 billion to $2.750 billion.
The tech firm posted Q3 2024 revenue of $725.5 million, representing a 30% year-over-year increase from $558.2 million in Q3 2023. This growth was significantly influenced by Palantir’s strategic focus on U.S. government contracts, which accounted for over 44% of total revenue, and U.S. commercial expansion, which saw substantial gains. The reported revenue surpassed analyst expectations of $701.1 million, according to LSEG.
Earnings per share (EPS) also exceeded forecasts, coming in at $0.10 adjusted compared to the anticipated $0.09, and doubling GAAP EPS from $0.03 in Q3 2023 to $0.06 this quarter. CEO Alex Karp attributed this performance to “unrelenting AI demand that won’t slow down,” emphasizing that the company’s strategy to capitalize on AI adoption across both governmental and private sectors is driving its top-line growth and profitability.
Adjusted income from operations for the quarter was $276 million, representing a 38% margin, up from $163.3 million, or 29% margin, in Q3 2023. Palantir also reported net income of $143.5 million, a 100% increase from $71.5 million in Q3 2023, as its investments in AI and data infrastructure began to yield substantial returns.
Following the earnings announcement, shares of Palantir surged 13% in after-hours trading, signaling investor optimism about the company’s growth trajectory in the evolving AI landscape.
Palantir’s deep involvement in government contracts has been a core driver of its revenue. The company posted a 40% year-over-year increase in U.S. government revenue, totaling $320 million, as federal agencies turn to Palantir for advanced AI and data visualization solutions, particularly within defense and intelligence sectors.
U.S. commercial revenue, however, outpaced even government spending, increasing 54% year-over-year to $179 million. Palantir’s Chief Financial Officer David Glazer highlighted that the company’s commercial clients, especially in the U.S., “make faster decisions to buy software,” enabling swifter growth compared to more deliberate government procurement cycles.
Palantir’s revenue growth was fueled by its generative AI products, notably its newest AI Platform (AIP), which has resonated with enterprise clients eager to implement large language models (LLMs) for tasks like testing, debugging, and scenario evaluation. As Palantir moves to leverage these tools for broader adoption, Karp projected a “U.S.-driven AI revolution,” asserting that the company is “at the center” of this technological transformation.
While U.S. clients have readily embraced these tools, Palantir’s international revenue has faced setbacks. Notably, commercial revenue from Europe declined by 7% quarter-over-quarter, a trend Glazer attributed to regional “challenges” and the scaling back of funding from a government-affiliated client in the Middle East.
In terms of cash flow, Palantir reported an adjusted free cash flow of $435 million for Q3 2024, representing a substantial margin of 60%. On a trailing twelve-month basis, the company’s free cash flow exceeded $1 billion, reflecting strong operational efficiency and prudent financial management, as Palantir’s cash reserves grew to $4.6 billion.
Looking ahead, Palantir has revised its revenue forecast for Q4, estimating between $767 million and $771 million, exceeding the $741.4 million anticipated by LSEG analysts. For the full year, the company’s latest guidance implies a 26% annual growth rate, supported by robust demand for AI technologies in the U.S. Palantir also increased its adjusted income from operations target for 2024 to $1.05 billion to $1.06 billion, up from a previous range of $966 million to $974 million.
Information for this briefing was found via Reuters, CNBC, and the sources mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
